食欲下降是肿瘤患者常见症状，可导致营养摄入不足，使患者出现全血细胞减少、体重下降、脂肪组织和骨骼 肌减少、生活质量下降等问题，不利于抗肿瘤治疗措施的实施。准确评估厌食症的过程，无论对研究还是临床管理都极为 重要，科学的食欲评价方法和技术不仅是营养工作者客观评价食欲的工具 , 也是进一步认识和预测营养不良的基础。本文 通过回顾国内外发表的肿瘤患者食欲评价及癌性厌食的相关文献，综述目前肿瘤患者食欲的评估方法及常用治疗药物，但 尚无一致认可的肿瘤患者食欲评估工具，常用方法包括：询问法、视觉模拟测量、厌食 / 恶液质治疗的功能评估、肿瘤患 者食欲症状问卷、简单营养食欲评估问卷及口头评价量表等，且各有侧重。尽管临床上可通过药物干预改善肿瘤患者的厌 食状况并增加体重，但仍需权衡药物的相关副作用，以期有效帮助肿瘤患者改善食欲，并使其获益最大。

Anorexia , a common symptom of cancer patients, is not conducive to the implementation of the anti-tumor treatment measures, it can lead to inadequate intake of nutrients, pancytopenia, weight loss, decrease of adipose tissue and skeletal muscle and decline their quality of life. Accurate assessment of the anorexia process is essential to both research and clinical management, scientific evaluation methods and techniques of appetite are not only a tool to objectively evaluate the appetite, but also the basic of further understanding and predicting the malnutrition. By reviewing domestic and foreign researches on the evaluation of appetite and cancerous anorexia, we summarized the evaluation methods and drugs commonly used. The appetite evaluation methods for cancer patients included inquiry method, VAS, FAACT-A/CS-12 and so on, each method had its own focus. However, there was no consensus on the appetite evaluation tool for cancer patients. Although the clinical treatment of anorexia could bring patients putting on weight, it was still necessary to take the side-effects of drugs into account, in order to effectively improved the anorexia situation of cancer patients and made the most of it.